Hum
Yes the company has three products.
$300,000 came from the CCT's, which will begin generated monthly revenue this year.
The CCT's will generate recurring revenue. If it had not been for Mr. Brumfield's son working with Carey and Wade, the CCT would not have been improved. The young man is making a really big difference, not only in the lab, but at the G4 set up as well.
The significant rise in income will come this year, imo.
The G4 will be the big growth for 2014, imo.
The feed back was noted in the latest SEC filing, and looks very promising.
2014 will bring this investor gains.
2014 will return value for the shareholders.
Ya don't have to wait any longer, here are da answers.
